FUSE — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-08-07

• For the three months ended June 30, 2026, and June 30, 2025, we generated revenues of $1.79 million and $2.03 million and reported a net loss of $2.85 million and $3.79 million, respectively. For the six months ended June 30, 2026, and June 30, 2025, we generated revenues of $3.67 million and $3.99 …

• Gain on change in fair value of forward purchase derivative liability $20 $0 $20 100%

• Deemed dividend related to Shortfall Warrants modification $0 $0 $-

• Weighted-average common shares outstanding - basic and diluted (ii) 28,965,344 7,270,964

• (1) (a) Includes stock-based compensation expense as follows:

Text removed vs the prior filing · source: 10-Q · 2026-05-15

• In February 2026, one of the Fusemachines employees exercised an aggregate of 1,715 options to purchase shares of Fusemachines common stock on a cashless basis via net share settlement resulting in the net share issuance of 974 shares of Fusemachines common stock. The transaction has been accounted …

• On April 17, 2026, subsequent to the balance sheet date of March 31, 2026, Fusemachines Inc. entered into a Common Stock Purchase Agreement (the “Purchase Agreement”) and a related Registration Rights Agreement with Roth Principal Investments, LLC (“Roth Principal Investments”), an affiliate of Roth…

• During the three months ended March 31, 2026, the Company reached a settlement agreement with a former service provider resolving an outstanding payable obligation. Under the terms of the settlement, the Company agreed to pay $320 thousand in full satisfaction of a vendor payable previously carried …

• For the three months ended March 31, 2026, and March 31, 2025, we generated revenues of $1.88 million and $1.95 million and reported a net loss of $0.87 million and $0.25 million, respectively. Net cash used in operating activities was $2.22 million for the three months ended March 31, 2026, and $0.…

• Gain on change in fair value of convertible notes, and warrant liability 60 1,516 (1,456) (96)%

Text added vs the prior filing · source: 10-Q · 2026-08-07

• Risks Related to the August 2026 Note and Warrant Financing with Meteora

• The issuance of shares upon conversion of the Notes and exercise of the Warrants will dilute our stockholders, and our obligation to register the resale of those shares, or our failure to meet the applicable filing and effectiveness deadlines, could adversely affect the trading price of our Common S…

• On August 2, 2026, we entered into separate Securities Purchase Agreements with certain accredited and institutional investors (collectively, the “Purchasers”), pursuant to which we issued 18% original issue discount senior unsecured convertible promissory notes due February 12, 2027 (the “Notes”) i…

• Amendments to our existing Forward Purchase Agreement and Shortfall Warrants with Meteora, entered into concurrently with the Notes and Warrants, could increase the dilutive impact and volatility of those instruments.

• Concurrently with the issuance of the Notes and Warrants, we entered into a Second Forward Purchase Agreement Confirmation Amendment and a Second Common Stock Purchase Warrant Amendment with certain of the Meteora entities. The Second Forward Purchase Agreement Confirmation Amendment resets the Term…